Loading…
Stryker Corporation is projected to rise to $357.71 by 2027, a +8% move from its current price of $329.78. SYK is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $324.20 | $329.74 | $335.38 | -0.01% |
| Jul 15 | $321.89 | $329.71 | $337.71 | -0.02% |
| Jul 16 | $320.13 | $329.67 | $339.50 | -0.03% |
| Jul 17 | $318.64 | $329.64 | $341.01 | -0.04% |
| Jul 18 | $317.34 | $329.60 | $342.34 | -0.05% |
| Jul 19 | $316.15 | $329.56 | $343.54 | -0.07% |
| Jul 20 | $315.07 | $329.53 | $344.65 | -0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $315.07 | $329.53 | $344.65 | -0.08% |
| Week 2 | $309.03 | $329.28 | $350.85 | -0.15% |
| Week 3 | $304.42 | $329.03 | $355.62 | -0.23% |
| Week 4 | $300.56 | $328.78 | $359.65 | -0.30% |
| Week 5 | $297.16 | $328.53 | $363.20 | -0.38% |
| Week 6 | $294.11 | $328.28 | $366.41 | -0.46% |
| Week 7 | $291.31 | $328.03 | $369.37 | -0.53% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Stryker Corporation is a medical technology company operating in the United States and internationally. It functions through the MedSurg and Neurotechnology, and Orthopaedics segments, offering surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism, traditional brain and open skull based surgical procedures, and orthobiologic and biosurgery products.
The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries, and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
SYK operates in the healthcare space with a current price of $329.78 and a market capitalization of $126.42B. It holds the 121st rank by market capitalization among its peers. The 2026 average forecast is $329.78, with a projected range from $282.58 to $409.04 and an implied ROI of 0% (neutral sentiment).
Looking further out, forecasts show a rising trajectory: the 2030 average is $511.70 with a max of $697.53 and a min of $399.69 (ROI 55.2%, bullish), the 2040 average is $984.86 with a max of $1,502.30 (ROI 198.6%, bullish), and the 2050 average is $2,013.32 with a max of $3,291.99 (ROI 510.5%, bullish).
A major floor 15.3% below — a decisive break under it would weaken the trend.
The nearest floor, 11.1% below — buyers have tended to step in here.
Price is pressing into resistance (0.9% away) — a breakout level to watch.
A major ceiling 16.6% above — clearing it would confirm fresh momentum.
Key SYK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SYK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $327.64 | Buy | $327.22 | Buy |
| MA 10 | $325.62 | Buy | $324.24 | Buy |
| MA 20 | $317.30 | Buy | $319.55 | Buy |
| MA 50 | $309.07 | Buy | $317.73 | Buy |
| MA 100 | $328.95 | Buy | $326.23 | Buy |
| MA 200 | $346.28 | Sell | $340.13 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 58.92 | Neutral |
| Stoch RSI (14) | 65.25 | Neutral |
| CCI (20) | 92.88 | Neutral |
| Williams %R (14) | -10.46 | Info |
| MACD (12,26,9) | 1.36 | Buy |
| ROC (12) | 6.38 | Buy |
| Bollinger %B (20,2) | 0.82 | Neutral |
| Stochastic %K (14) | 89.54 | Sell |
| TRIX (15) | 0.19 | Buy |
| Awesome (5,34) | 15.09 | Buy |
| Ultimate (7,14,28) | 70.93 | Sell |
| Momentum (10) | 13.67 | Buy |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 330.00 | Sell |
| ADX (14) | 12.97 | Neutral |
| ATR (14) | 5.18 | Info |
30-day technical picture:
- Sentiment: BULLISH with RSI14 at 60. - Moving averages: SMA50 is $309.07 and SMA200 is $346.28. - Support and resistance: support at $293.30 and resistance at $332.71. - 30-day range: $294.90 to $368.79.
Annualized volatility is 30%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $282.58 | $329.78 | $408.66 | 0% | Neutral | |
| $292.99 | $357.71 | $456.58 | +8% | Neutral | |
| $310.92 | $386.75 | $507.01 | +17% | Neutral | |
| $352.98 | $445.83 | $596.93 | +35% | Bullish | |
| $398.77 | $510.48 | $695.80 | +55% | Bullish | |
| $438.27 | $567.90 | $786.31 | +72% | Bullish | |
| $440.36 | $577.06 | $810.36 | +75% | Bullish | |
| $445.10 | $589.41 | $838.43 | +79% | Bullish | |
| $484.37 | $647.79 | $932.48 | +96% | Bullish | |
| $517.31 | $698.40 | $1,016.53 | +112% | Bullish | |
| $700.40 | $986.24 | $1,504.34 | +199% | Bullish | |
| $1,331.93 | $2,011.47 | $3,288.86 | +510% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $282.58 | $329.78 | $390.83 | +0.00% |
| August 2026 | $277.93 | $325.26 | $388.83 | -1.37% |
| September 2026 | $277.66 | $326.52 | $393.42 | +0.39% |
| October 2026 | $283.69 | $334.98 | $406.29 | +2.59% |
| November 2026 | $283.08 | $335.44 | $409.11 | +0.14% |
| December 2026 | $280.43 | $333.37 | $408.66 | -0.62% |
Click any year to see its month-by-month SYK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Stryker Corporation's 2026 outlook centres on $329.78, within a $282.58 to $408.66 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SYK could reach as high as $456.58, with a base case around $357.71 and support toward $292.99 — roughly +8% from $329.78. A consolidation phase looks the most probable path here.
Expect SYK to range from $310.92 to $507.01 through 2028. The $386.75 average target implies a +17% move from current prices. That is up +8% on the projected 2027 average. Price action looks broadly range-bound.
The SYK price prediction for 2029 points to an average of $445.83 (low $352.98, high $596.93) — a potential gain of +35% on today's $329.78. Buyers look set to stay in control over this stretch.
In 2030, SYK is projected to trade between $398.77 and $695.80, averaging $510.48 — a potential gain of +55% from today's $329.78. That is up +14% on the projected 2029 average. Momentum favours further upside here.
Stryker Corporation's 2031 outlook centres on $567.90, within a $438.27 to $786.31 range. That is up +11% on the projected 2030 average. That marks a +72% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SYK could reach as high as $810.36, with a base case around $577.06 and support toward $440.36 — roughly +75% from $329.78. Momentum favours further upside here.
Expect SYK to range from $445.10 to $838.43 through 2033. The $589.41 average target implies a +79% move from current prices. That is up +2% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SYK price prediction for 2034 points to an average of $647.79 (low $484.37, high $932.48) — a potential gain of +96% on today's $329.78. Momentum favours further upside here.
In 2035, SYK is projected to trade between $517.31 and $1,016.53, averaging $698.40 — a potential gain of +112% from today's $329.78. That is up +8% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Stryker Corporation's 2040 outlook centres on $986.24, within a $700.40 to $1,504.34 range. That is up +41% on the projected 2035 average. That marks a +199% change versus current levels. Momentum favours further upside here.
By 2050, SYK could reach as high as $3,288.86, with a base case around $2,011.47 and support toward $1,331.93 — roughly +510% from $329.78. Buyers look set to stay in control over this stretch.
Investing $1,000 in SYK today (≈ 3.032325 SYK) could be worth
$6,099.44
+$5,099.44 (+510%) by 2050 · US Dollar
Based on the average projected SYK price of $2,011.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SYKwould be worth at today's price.
$1,000 invested in SYK on Jul 10, 2025 (≈ 2.533121 SYK) would be worth
$835.37
-$164.63 (-16.5%) today · 0.84× · US Dollar
Based on a SYK entry price of $394.77 vs. today's $329.78.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $326.54 | $1,009.92 | +1.0% |
| 1 month ago | $308.84 | $1,067.8 | +6.8% |
| 3 months ago | $339.15 | $972.37 | -2.8% |
| 6 months ago | $361.37 | $912.58 | -8.7% |
| 1 year ago | $394.77 | $835.37 | -16.5% |
| All time (5.0y) ago | $261.36 | $1,261.78 | +26.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SYK forecast.
Our base-case forecast reaches $660.00 around 2035.
Implied market cap at $660.00: $253.02B
Interpreting the multi-year forecast, the 2026 avg price is $329.78, with a min of $282.58 and a max of $409.04, and an ROI of 0% (neutral sentiment) indicating a baseline start.
For 2030, the avg rises to $511.70 with a min of $399.69 and a max of $697.53, an ROI of 55.2%, and bullish sentiment, signaling meaningful upside potential if the trajectory continues.
In 2040, the avg is $984.86 with a min of $699.39 and a max of $1,502.30, ROI of 198.6%, and bullish sentiment, reflecting substantial longer-term appreciation.
By 2050, the avg reaches $2,013.32 with a min of $1,333.11 and a max of $3,291.99, ROI of 510.5%, and bullish sentiment, suggesting a strong long-term upside scenario. These figures are estimates and not guarantees, and actual results may differ due to market conditions and other factors.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $511.70, with a min of $399.69 and a max of $697.53, ROI 55.2%, sentiment BULLISH.
Yes. The 2035 forecast lists a max of $1,017.94 with a 2030 max of $697.53, indicating a possibility to exceed $1,000 by 2035. For 2035 the min is $517.97, avg $699.32, max $1,017.94, ROI 112.1%, sentiment BULLISH.
Current price is $329.78 and market cap is $126.42B.
The 30-day picture shows bullish sentiment with RSI14 at 60. SMA50 is $309.07, SMA200 is $346.28, support at $293.30, resistance at $332.71, and a 30-day range of $294.90 to $368.79. Annualized volatility is 30%.
2040: avg $984.86, min $699.39, max $1,502.30, ROI 198.6%, sentiment BULLISH. 2050: avg $2,013.32, min $1,333.11, max $3,291.99, ROI 510.5%, sentiment BULLISH.
Stryker Corporation Community Discussion
0Share your Stryker Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.